Active implantable device vulnerability to interference from theft detection systems probed by FDA.
This article was originally published in The Gray Sheet
Executive Summary
ACTIVE IMPLANTS' VULNERABILITY TO RETAIL STORE SECURITY SYSTEM INTERFERENCE is being investigated by FDA. The agency is asking manufacturers of electronic article surveillance (EAS) systems to submit data to help it determine if the systems, which are commonly found in retail stores, pose a risk of electromagnetic interference with pacemakers, implantable cardioverter defibrillators, and other active implantable medical devices.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.